PotentiaMetrics Featured on Civil Discourse Podcast
October 1, 2021
In an era of increasing outcomes transparency, providers must define and demonstrate improved clinical and economic outcomes. PotentiaMetrics enhances medical evidence with proprietary AI platforms supported by real-world clinical and economic outcomes data. PotentiaMetrics outcomes and insights products deliver information not available from other sources that enhance the current evidence base, by frequently revealing new information, and contradicting previous findings. As a result, our customers have actionable insights that improve patient outcomes, accelerate contribution margins, and decrease healthcare spending. Payers, providers, employers and medical-technology companies use our platforms to compare effectiveness, adjust for risk, and track outcomes-based performance metrics.
PotentiaMetrics Featured on Brains Behind AI Podcast
October 23, 2020
On this episode of Brains Behind AI, Ari and Natalie met with Bobby Palmer, the President and CEO of PotentiaMetrics, an Austin-based healthcare data and AI company. PotentiaMetrics’ data analytics and artificial intelligence platforms help providers, payers and medical technology companies inform personalized treatment plans by comparing patient-level outcome data related to survival, quality of life and cost of care. These companies use PotentiaMetrics platforms to compare effectiveness, adjust for risk, and track outcomes-based performance metrics.
Bobby has been a business owner and CEO for over 20 years, creating the vision and strategic direction to develop multi-institutional, real-world outcomes registries that enable the creation of unique and personalized AI platforms. Bobby received his MBA from Washington University in St. Louis.
PotentiaMetrics Announces the Appointment of Dr. Jerry Henderson as Chief Medical Officer
October 8, 2019
Austin, Texas / PRWEB/ October 8, 2019 –POTENTIAMETRICS, an Austin, TX based healthcare data and artificial intelligence company, appointed distinguished innovator, Dr. Jerry Henderson as Chief Medical Officer. Dr. Henderson will be responsible for the development and management of the firms’ clinical data registries analytics platforms.
PotentiaMetrics Announces the Fifth and Sixth Members of its MyCancerJourney Clinical Advisory Board; Jonathan Heinlen, M.D. and Tara Kaufmann, M.D.
April 8, 2019
Austin, Texas / PRWEB/ April 8, 2019 –POTENTIAMETRICS, an Austin, TX based healthcare data and artificial intelligence company, announced the addition of Jonathan Heinlen, M.D. and Tara Kaufmann, M.D. to the ranks of its stellar advisory board of specialists, MDs and medical researchers.
PotentiaMetrics Announces Additions to its Clinical Advisory Board with Doctors Carolyn Presley and Michael Papagikos
April 1, 2019
Austin, Texas / PRWEB/ April 1, 2019 –POTENTIAMETRICS, an Austin, TX based healthcare data and artificial intelligence company, announced the addition of Carolyn Presley, M.D. MHS and Michael Papagikos, M.D to the ranks of its stellar group of specialists, MDs and medical researchers committed to empowering patients with the strongest data in cancer.
Potentiametrics Announces the Addition of George Lundberg, M.D. to MyCancerJourney Clinical Advisory Board
March 25, 2019
Austin, Texas / PRWEB/ March 25, 2019 –POTENTIAMETRICS, an Austin, TX based healthcare data and artificial intelligence company, announced the formation of The MyCancerJourney Clinical Advisory Board, a stellar group of specialists, MDs, and medical researchers committed to empowering patients with the strongest data in cancer.
PotentiaMetrics Announces the Formation of Clinical Advisory Board Committed to Empowering Patients with Cancer using AI Platform — MyCancerJourney
March 18, 2019
Austin, Texas / PRWEB/ March 18, 2019 — POTENTIAMETRICS, an Austin, TX based healthcare data and analytics company, announced the formation of The MyCancerJourney Clinical Advisory Board (CAB).
PotentiaMetrics and Ascend Collaborate to Launch Disruptive Cancer Outcomes Platform
September 27, 2018
Austin, Texas / PRWEB/ September 27, 2018 — MyCancerJourney empowers patients with actionable information to improve the patient experience, improve outcomes while saving millions of dollars for patients and self-insured employers.
PotentiaMetrics selected as Top 10 Innovators in Cancer at MedCity’s CONVERGE Conference in Philadelphia
July 12, 2018
Study: Cerebral oximetry monitoring linked to fewer complications after cardiac surgery
Written by Jessica Kim Cohen | Becker’s Hospital Review | January 8, 2018
Monitoring cardiac surgery patients’ cerebral oximetry levels may lead to reduced surgical complications and 30-day readmissions, according to a study published in the Harvard Health Policy Review Jan. 7.
4 questions with PotentiaMetrics CEO Robert Palmer on personalized healthcare
Written by Jessica Kim Cohen | Becker’s IT & CIO Review | Jan 3, 2018
Robert Palmer boasts 20-plus years of experience in data analytics — but he chose to focus his career on healthcare after his father was diagnosed with metastatic cancer.
PotentiaMetrics recognized by GuideWell for innovative and disruptive Analytics and AI platform for cancer patients
Winner of the People’s Choice Award | April 27, 2017
PotentiaMetrics recognized by Joe Biden (Biden Foundation) at SXSW for innovation in cancer outcomes Analytics and AI
March 12, 2017
PotentiaMetrics Selected for GuideWell Innovation and Healthbox Program
May 31, 2016
AUSTIN, Texas, May 31, 2016 /PRNewswire/ — PotentiaMetrics announces selection to participate in The Healthbox Florida Studio in Partnership with GuideWell Innovation, an eight-week studio at the new GuideWell Innovation CoRE™ (Collaborative Resource Ecosystem) space in Lake Nona Medical City, Orlando, Florida.